Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactio...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2025-05-01
Sarja:	Clinical and Translational Science
Aiheet:	medical oncology pediatrics pharmacogenetics pharmacogenomics precision medicine
Linkit:	https://doi.org/10.1111/cts.70246
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!